Literature DB >> 1976223

Mechanism of action of somatostatin: an overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins.

Y C Patel1, K K Murthy, E E Escher, D Banville, J Spiess, C B Srikant.   

Abstract

To determine whether somatostatin receptor subtypes arise from molecular heterogeneity of the receptor protein, we have cross-linked the putative receptor in normal rat tissues and in AtT-20 and GH3 cells, both chemically with SS-14, SS-28 and Tyr3 SMS ligands, as well as by photoaffinity labeling with an azido derivative of Tyr3 SMS (EE 581). Three prominent somatostatin receptor proteins of 58-kDa, 32-kDa, and 27-kDa size have been identified. These proteins exhibit a tissue-specific distribution, ligand selectivity, and relative preference for SS-14 and SS-28 binding, and thus qualify as somatostatin receptor subtypes. Using EE 581 as a photoaffinity probe, the 58-kDa and 32-kDa proteins have been purified to homogeneity from brain and AtT-20 cells by successive SDS-PAGE. The 58-kDa form has been trypsinized and amino acid sequence data obtained from four tryptic fragments. With the help of synthetic oligonucleotides derived from these sequences, work is currently in progress to clone the 58-kDa protein to elucidate its complete sequence, its expression, and its functional relationship to the somatostatin receptor and its pharmacological subtypes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976223     DOI: 10.1016/0026-0495(90)90214-w

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  11 in total

Review 1.  The therapeutic value of somatostatin and its analogues.

Authors:  S Farooqi; J S Bevan; M C Sheppard; J A Wass
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

2.  Development of antibodies against the rat brain somatostatin receptor.

Authors:  M Theveniau; S Rens-Domiano; S F Law; G Rougon; T Reisine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

3.  Tissue-specific distribution of cross-linked somatostatin receptor proteins in the rat.

Authors:  C B Srikant; K K Murthy; Y C Patel
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

4.  Diagnosis and treatment of Cushing's syndrome. Cushing's syndrome: current clinical problems, symposium. Padova, October 19-20, 1990.

Authors: 
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

5.  The helix-loop-helix transcription factor SEF-2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene.

Authors:  A Pscherer; U Dörflinger; J Kirfel; K Gawlas; J Rüschoff; R Buettner; R Schüle
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

Review 6.  Molecular pharmacology of somatostatin receptor subtypes.

Authors:  Y C Patel
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

7.  Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells.

Authors:  I Rauly; N Saint-Laurent; N Delesque; L Buscail; J P Estéve; N Vaysse; C Susini
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

8.  Co-purification of a protein tyrosine phosphatase with activated somatostatin receptors from rat pancreatic acinar membranes.

Authors:  M Zeggari; J P Esteve; I Rauly; C Cambillau; H Mazarguil; M Dufresne; L Pradayrol; J A Chayvialle; N Vaysse; C Susini
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

9.  Inhibitory activity of the peptides derived from buffalo prolactin on angiogenesis.

Authors:  Jaeok Lee; Syamantak Majumder; Suvro Chatterjee; Kambadur Muralidhar
Journal:  J Biosci       Date:  2011-06       Impact factor: 1.826

Review 10.  Common tools for pituitary adenomas research: cell lines and primary cells.

Authors:  Ziyan Zhu; Weiwei Cui; Dimin Zhu; Nailin Gao; Yonghong Zhu
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.